For men with intermediate-risk, localized prostate cancer, five-session stereotactic body radiation therapy reduced patient-reported side effects compared with longer courses of therapy, according to study results presented September 30 at the…
For men with intermediate-risk, localized prostate cancer, five-session stereotactic body radiation therapy reduced patient-reported side effects compared with longer courses of therapy, according to study results presented September 30 at the…